Skip to main content

Table 6 Clinicopathologic variables associated with overall survival

From: Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study

Variables Univariate analysis
HR 95% CI P-value
  Non-endometrioid vs. endometrioid 4.523 1.137–17.993 0.032
CA-125 at diagnosis, IU/ml
  ≥190 vs. <190 1.965 0.568–6.796 0.286
Residual tumor after IDS
  Any RT vs. NGR 2.738 0.754–9.945 0.126
  1. Abbreviations: FIGO International Federation of Gynecology and Obstetrics, IDS Interval debulking surgery, RT residual tumor, NGR no gross residual, HR hazard ratio, 95% CI 95% confidence interval